SSRI use and clinical outcomes in epithelial ovarian cancer

Authors

Desire K. Christensen, University of Iowa
Guillermo N. Armaiz-Pena, Ponce Health Sciences University
Edgardo Ramirez, University of Iowa
Koji Matsuo, University of Southern California, Los Angeles
Bridget Zimmerman, University of Iowa
Behrouz Zand, UT MD Anderson Comprehensive Cancer Center
Eileen Shinn, UT MD Anderson Comprehensive Cancer Center
Michael J. Goodheart, University of Iowa
David Bender, University of Iowa
Premal H. Thaker, Washington University
Amina Ahmed, Lutheran General Hospital
Frank J. Penedo, Northwestern University
Koen DeGeest, Oregon Health and Sciences University
Luis Mendez, Herbert Wertheim College of Medicine, Florida International University
Frederick Domann, University of Iowa
Anil K. Sood, UT MD Anderson Comprehensive Cancer Center
Susan K. Lutgendorf, University of Iowa

Date of this Version

4-21-2016

Document Type

Article

Originally Published In

Oncotarget

PMID

27121207

DOI

10.18632/oncotarget.8891

Recommended Citation

Christensen, Desire K.; Armaiz-Pena, Guillermo N.; Ramirez, Edgardo; Matsuo, Koji; Zimmerman, Bridget; Zand, Behrouz; Shinn, Eileen; Goodheart, Michael J.; Bender, David; Thaker, Premal H.; Ahmed, Amina; Penedo, Frank J.; DeGeest, Koen; Mendez, Luis; Domann, Frederick; Sood, Anil K.; and Lutgendorf, Susan K., "SSRI use and clinical outcomes in epithelial ovarian cancer" (2016). All Faculty. 165.
https://digitalcommons.fiu.edu/all_faculty/165

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.